Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · S 4939

Countering CCP Act

Refreshed 27 min ago

Introduced 2026-06-24Topic: health care · technology privacy

Summary

AI-generated summary, report an error

This bill would require the Food and Drug Administration, working with the Cybersecurity and Infrastructure Security Agency, to review internet-connected medical devices made by manufacturers headquartered in or owned or controlled by China for cybersecurity issues. Within 180 days, the agency would request information from these manufacturers, including software components and the locations of servers holding patient data. Within 18 months, devices found to pose a cybersecurity risk would be ordered to stop being distributed, and health providers and affected patients would be notified. Devices whose makers do not provide the requested information within 180 days would face the same order, unless a recall would cause a shortage that endangers patients. The agency would also report to Congress within 2 years on the device industry's cyber preparedness and Chinese manufacturers' market share.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-06-24SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.refer
2026-06-24Introduced in Senateintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.